{"transactions":[{"id":2633215,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-07-15T18:07:55.000Z","date":"2021-07-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 40,000 restricted stock units granted on July 13, 2021 (the \"Grant Date\") under the Issuer's 2020 Equity Incentive Plan which will vest 50% on the six month anniversary of the Grant Date and the remaining 50% on the one year anniversary of the Grant Date."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001104659-21-092719","document":"tm2122331-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000110465921092719/tm2122331-6_4seq1.xml","form_type":"4"}},{"id":2958726,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:57.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.972,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-132156","document":"tm2037705d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000110465920132156/tm2037705d8_4seq1.xml","form_type":"4"}},{"id":2958725,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:57.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.8203,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132156","document":"tm2037705d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000110465920132156/tm2037705d8_4seq1.xml","form_type":"4"}},{"id":2958724,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:57.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":4.06,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132156","document":"tm2037705d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000110465920132156/tm2037705d8_4seq1.xml","form_type":"4"}},{"id":2958723,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:57.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":3.93,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132156","document":"tm2037705d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000110465920132156/tm2037705d8_4seq1.xml","form_type":"4"}},{"id":2958722,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:57.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":8.9125,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132156","document":"tm2037705d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000110465920132156/tm2037705d8_4seq1.xml","form_type":"4"}},{"id":2958721,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:57.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":7813,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":7.55,"underlying":"Common Stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001104659-20-132156","document":"tm2037705d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000110465920132156/tm2037705d8_4seq1.xml","form_type":"4"}},{"id":2965274,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-27T17:10:24.000Z","date":"2020-11-24","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will immediately vest and become exercisable subject to and upon consummation of (1) the merger of PM Merger Sub 1, LLC with and into Metuchen Pharmaceuticals, LLC (\"Metuchen\"), with Metuchen surviving as a wholly-owned subsidiary of Petros Pharmaceuticals, Inc. (\"Petros\") and (2) the merger of PN Merger Sub 2, Inc. with and into Neurotrope, Inc. (\"Neurotrope\"), with Neurotrope surviving as a wholly-owned subsidiary of Petros (together, the \"Mergers\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In the event the reporting person departs from the board of directors following the consummation of the Mergers, the options shall expire on the date that is one year from the date of the consummation of the Mergers."}],"balance_after":15000,"derivative":{"exercise_price":0.972,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-130082","document":"tm2037145d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000110465920130082/tm2037145d8_4seq1.xml","form_type":"4"}},{"id":3196557,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-24T18:00:25.000Z","date":"2020-03-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option award was made in connection with the Issuer's annual equity grants to non-employee directors pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan."}],"balance_after":10000,"derivative":{"exercise_price":0.8203,"exercise_date":"2021-03-20","expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-037863","document":"tm2013506d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000110465920037863/tm2013506d1_4.xml","form_type":"4"}},{"id":3555867,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-15T17:00:51.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option award was made in connection with the Issuer's annual equity grants to non-employee directors pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan."}],"balance_after":10000,"derivative":{"exercise_price":4.06,"exercise_date":"2020-03-15","expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-19-019709","document":"tv518872_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000114420419019709/tv518872_form4.xml","form_type":"4"}},{"id":3688156,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-24T18:03:58.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was made pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan. The stock options shall vest according to the following schedule: 50% vest on the date of grant, with the remaining stock options vesting in equal quarterly installments over a two-year period following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":3.93,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-19-002689","document":"tv511530_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000114420419002689/tv511530_4.xml","form_type":"4"}},{"id":3994774,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-15T17:02:08.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual option grant to each of the Issuer's non-employee directors on the fifth business day after the Issuer's filing of its Annual Report on Form 10-K pursuant to the Issuer's Nonemployee Director Compensation Policy."}],"balance_after":10000,"derivative":{"exercise_price":8.9125,"exercise_date":"2019-03-13","expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-18-014962","document":"tv488496_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000114420418014962/tv488496_form4.xml","form_type":"4"}},{"id":4128756,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":137302,"kind":"person","name":"Perry George","position":1,"cik":"0001725758","reported_name":"Perry George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-12-18T17:27:41.000Z","date":"2017-12-14","kind":"grant","acquired":true,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued in connection with the Reporting Person's appointment as a non-employee director to the Issuer's board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options shall vest in equal daily installments over a five-year period beginning on the date of grant."}],"balance_after":7813,"derivative":{"exercise_price":7.55,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001144204-17-064168","document":"tv481439_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725758/000114420417064168/tv481439_form4.xml","form_type":"4"}}]}